• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Corcept Therapeutics Inc

+ Add to Watchlist


2.4900 USD 0.0500 2.05%

As of 20:10:00 ET on 07/11/2014.

Snapshot for Corcept Therapeutics Inc (CORT)

Open: 2.4200 Day's Range: 2.4200 - 2.6300 Volume: 99,587
Previous Close: 2.4400 52wk Range: 1.4700 - 4.4900 1-Yr Rtn: +38.33%

Stock Chart for CORT

No chart data available.
  • CORT:US 2.5000
  • 1D
  • 1M
  • 1Y
Interactive CORT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CORT

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.4800
Est. EPS (USD) (12/2014) -0.3750
Est. PEG Ratio -
Market Cap (M USD) 251.23
Shares Outstanding (M) 100.89
30 Day Average Volume 343,093
Price/Book (mrq) 26.7544
Price/Sale (ttm) 19.0988
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/08/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CORT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CORT

Corcept Therapeutics Inc. is a pharmaceutical company that discovers and develops drugs for the treatment of severe metabolic and psychiatric disorders. The Company's lead product modulates the effect of cortisol, also known as the "stress hormone", by selectively blocking the binding of cortisol to one of its two known receptors, the GR-II receptor.

Joseph K BelanoffPresident/CEO/Co-FounderGary Charles Robb "Charlie"CFO/Secretary
Steven LoSenior VP/Chief Commercial OfcrAnne M LedouxVP/Chief Acctg Officer
More Company Profile & Key Executives for CORT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil